Cash flow Shenyang Xingqi Pharmaceutical Co.,Ltd.

Equities

300573

CNE100002DV1

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 2025-07-18			5-day change	1st Jan Change
55.30 ^CNY	-0.09%		+3.58%	+10.95%

06-17	Xingqi Pharmaceutical Begins Phase Three Trial for Anesthetic Gel	MT
05-30	Xingqi Pharmaceutical Says No Adverse Effects Seen in Phase 1 Eye Drops Trial	MT

cbb.oj6NlpfGl4X-TaXTG69vRz6doGvY-ORUc6RoaDrrVr4.j1C0xNmB-taVNJeDLP4-GGv07zSqjrwyHsoyUQqqZt2QdrT3-Izn1591lQ

Published financial data: SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	683M	1.02B	1.23B	1.44B	1.92B
Other Revenues, Total	5.46M	3.6M	23.2M	27.86M	19.49M
Total Revenues	689M	1.03B	1.25B	1.47B	1.94B
Cost of Goods Sold, Total	188M	229M	270M	340M	425M
Gross Profit	501M	799M	980M	1.13B	1.52B
Selling General & Admin Expenses, Total	321M	457M	595M	690M	876M
Provision for Bad Debts	1.04M	-187K	926K	3.03M	3.32M
R&D Expenses	63.19M	88.45M	146M	167M	221M
Other Operating Expenses	9.81M	13.8M	6.66M	7.16M	10.68M
Other Operating Expenses, Total	395M	559M	749M	867M	1.11B
Operating Income	105M	240M	231M	260M	408M
Interest Expense, Total	-5.94M	-5.99M	-937K	-1.44M	-5.71M
Interest And Investment Income	221K	3.98M	9.93M	7.91M	5.66M
Net Interest Expenses	-5.72M	-2.02M	9M	6.48M	-55.24K
Currency Exchange Gains (Loss)	-22.54K	-125K	-89.63K	200K	-109K
Other Non Operating Income (Expenses)	-546K	-1.05M	-917K	-1.15M	-2.11M
EBT, Excl. Unusual Items	99.14M	237M	239M	265M	406M
Gain (Loss) On Sale Of Investments	-	-	-	-	-24.24K
Gain (Loss) On Sale Of Assets	-77.81K	5.16M	421K	-37.53K	-978K
Asset Writedown	-	-1.68K	-4.9K	-	-14.05M
Other Unusual Items	3.48M	1.26M	-5.88M	-421K	3.94M
EBT, Incl. Unusual Items	103M	244M	234M	265M	395M
Income Tax Expense	9.08M	34.43M	22.03M	24.96M	56.97M
Earnings From Continuing Operations	93.46M	209M	212M	240M	338M
Net Income to Company	93.46M	209M	212M	240M	338M
Minority Interest	-5.48M	-14.41M	-	-	-
Net Income - (IS)	87.98M	195M	212M	240M	338M
Net Income to Common Incl Extra Items	87.98M	195M	212M	240M	338M
Net Income to Common Excl. Extra Items	87.98M	195M	212M	240M	338M
Per Share Items
Net EPS - Basic	0.4	0.87	0.88	0.98	1.39
Basic EPS - Continuing Operations	0.4	0.87	0.88	0.98	1.39
Basic Weighted Average Shares Outstanding	221M	223M	241M	244M	244M
Net EPS - Diluted	0.39	0.87	0.88	0.98	1.38
Diluted EPS - Continuing Operations	0.39	0.87	0.88	0.98	1.38
Diluted Weighted Average Shares Outstanding	224M	225M	241M	244M	245M
Normalized Basic EPS	0.26	0.6	0.62	0.68	1.04
Normalized Diluted EPS	0.25	0.59	0.62	0.68	1.04
Dividend Per Share	0.09	0.24	0.55	1.89	1.07
Payout Ratio	18.41	24.21	38.19	74.36	138.01
Supplemental Items
EBITDA	150M	297M	295M	338M	500M
EBITA	106M	241M	232M	261M	415M
EBIT	105M	240M	231M	260M	408M
EBITDAR	152M	299M	296M	339M	501M
Total Revenues (As Reported)	689M	1.03B	1.25B	1.47B	1.94B
Effective Tax Rate - (Ratio)	8.86	14.14	9.43	9.42	14.42
Current Domestic Taxes	9.55M	-	-	-	55.13M
Total Current Taxes	9.55M	37.03M	27.66M	24.22M	55.13M
Deferred Domestic Taxes	-469K	-	-	-	1.84M
Total Deferred Taxes	-469K	-2.59M	-5.63M	736K	1.84M
Normalized Net Income	56.48M	134M	149M	166M	254M
Interest on Long-Term Debt	-	11.31M	599K	557K	239K
Supplemental Operating Expense Items
Advertising Expense	6.89M	5.22M	13M	13.81M	42.52M
Marketing Expenses	-	-	-	-	-
Selling and Marketing Expenses	244M	338M	463M	535M	705M
General and Administrative Expenses	75.46M	118M	132M	154M	170M
Research And Development Expense From Footnotes	63.19M	88.45M	146M	167M	226M
Net Rental Expense, Total	1.66M	1.89M	534K	1.38M	1.55M
Imputed Operating Lease Interest Expense	930K	947K	64.05K	342K	482K
Imputed Operating Lease Depreciation	735K	943K	470K	1.04M	1.07M
Maintenance & Repair Expenses, Total	-	-	-	-	-
Stock-Based Comp., COGS (Total)	-	-	-	1.68M	857K
Stock-Based Comp., R&D Exp. (Total)	-	-	-	5.2M	2.72M
Stock-Based Comp., S&M Exp. (Total)	-	-	-	10.29M	4.77M
Stock-Based Comp., G&A Exp. (Total)	4.19M	13.31M	11.01M	6.25M	3.21M
Total Stock-Based Compensation	4.19M	13.31M	11.01M	23.42M	11.55M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	37.22M	686M	515M	480M	370M
Total Cash And Short Term Investments	37.22M	686M	515M	480M	370M
Accounts Receivable, Total	158M	171M	195M	252M	278M
Other Receivables	3.15M	5.84M	4.62M	3.93M	3.37M
Total Receivables	161M	176M	200M	256M	281M
Inventory	68.31M	92.33M	122M	136M	154M
Other Current Assets, Total	27.32M	29.27M	27.87M	32.71M	24.9M
Total Current Assets	294M	984M	865M	905M	830M
Gross Property Plant And Equipment	812M	892M	1.1B	1.32B	1.51B
Accumulated Depreciation	-285M	-343M	-403M	-484M	-517M
Net Property Plant And Equipment	528M	549M	696M	837M	992M
Long-term Investments	-	-	-	-	10M
Other Intangibles, Total	23.83M	22.83M	27.66M	78.29M	135M
Deferred Tax Assets Long-Term	33.87M	30.45M	23.77M	38.57M	22.5M
Deferred Charges Long-Term	28.22M	60.77M	105M	119M	64.44M
Other Long-Term Assets, Total	57.67M	39.78M	65.39M	45.68M	74M
Total Assets	966M	1.69B	1.78B	2.02B	2.13B
Liabilities
Accounts Payable, Total	6.67M	13.31M	19.46M	17.57M	17.73M
Accrued Expenses, Total	91.39M	109M	104M	125M	178M
Short-term Borrowings	80M	100M	-	70.06M	200M
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	-	4.18M	7.12M	6.87M	6.28M
Current Income Taxes Payable	-	11.69M	-	5.74M	22.84M
Unearned Revenue Current, Total	5.11M	6.11M	2.01M	6.55M	3.46M
Other Current Liabilities	29.34M	22.63M	19.89M	27.98M	32.67M
Total Current Liabilities	212M	267M	152M	260M	461M
Long-Term Debt	-	-	-	-	-
Long-Term Leases	-	7.1M	6.69M	2.22M	8.86M
Unearned Revenue Non Current	59.15M	68.42M	71.5M	71.58M	64.13M
Total Liabilities	272M	342M	231M	334M	534M
Common Stock, Total	82.37M	88.1M	88.56M	125M	175M
Additional Paid In Capital	288M	783M	852M	891M	867M
Retained Earnings	327M	479M	611M	674M	551M
Treasury Stock	-13.26M	-5.28M	-	-	-
Comprehensive Income and Other	-2.2M	-	-	-	-
Total Common Equity	682M	1.34B	1.55B	1.69B	1.59B
Minority Interest	11.87M	-	-	-	-
Total Equity	694M	1.34B	1.55B	1.69B	1.59B
Total Liabilities And Equity	966M	1.69B	1.78B	2.02B	2.13B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	226M	242M	243M	244M	245M
ECS Total Common Shares Outstanding	226M	242M	243M	244M	245M
Book Value / Share	3.02	5.56	6.39	6.92	6.49
Tangible Book Value	658M	1.32B	1.52B	1.61B	1.46B
Tangible Book Value Per Share	2.91	5.47	6.27	6.6	5.94
Total Debt	80M	111M	13.81M	79.15M	215M
Net Debt	42.78M	-575M	-502M	-401M	-155M
Debt Equivalent Oper. Leases	13.32M	15.13M	4.27M	11.07M	12.43M
Minority Interest, Total (Incl. Fin. Div)	11.87M	-	-	-	-
Account Code - Inventory Valuation	6	6	3	6	6
Inventories - Raw Materials, Total	41.14M	48.07M	54.96M	56.27M	68.26M
Inventories - Work In Process, Total	15.81M	21.37M	34.33M	37.89M	19.23M
Inventories - Finished Goods, Total	11.03M	25.12M	33.67M	46.55M	63.07M
Inventories - Others	4.64M	4.78M	8.3M	8.67M	10.05M
Buildings, Total	347M	350M	471M	477M	517M
Machinery, Total	439M	481M	534M	712M	760M
Full Time Employees	1.1K	-	1.76K	2K	2.43K
Accumulated Allowance for Doubtful Accounts (Supple)	7.38M	6.97M	7.89M	10.93M	12.93M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	87.98M	195M	212M	240M	338M
Depreciation & Amortization - CF	44.29M	66.04M	72.08M	84.89M	92.91M
Amortization of Goodwill and Intangible Assets - (CF)	534K	534K	534K	1.39M	7M
Depreciation & Amortization, Total	44.82M	66.57M	72.61M	86.28M	99.92M
Amortization of Deferred Charges, Total - (CF)	4.03M	6.92M	7.42M	7.06M	6.58M
(Gain) Loss From Sale Of Asset	77.81K	-5.16M	-421K	37.53K	978K
(Gain) Loss on Sale of Investments - (CF)	-	-3.14M	-	-	-
Asset Writedown & Restructuring Costs	3.92M	1.68K	4.9K	-	14.05M
Provision and Write-off of Bad Debts	-	-187K	926K	3.03M	3.32M
Other Operating Activities, Total	11.44M	24.49M	5.53M	10.23M	10.54M
Change In Accounts Receivable	-61.27M	-33.43M	-37.51M	-104M	-144M
Change In Inventories	8.71M	-27.8M	-34.35M	-22.05M	-20.99M
Change In Accounts Payable	18.72M	73.27M	23.51M	73.17M	95.54M
Change In Deferred Taxes	-469K	-2.59M	-5.62M	736K	1.84M
Change in Other Net Operating Assets	4.19M	13.31M	42.47M	23.42M	11.55M
Cash from Operations	122M	307M	286M	318M	417M
Capital Expenditure	-108M	-95.06M	-299M	-262M	-199M
Sale of Property, Plant, and Equipment	4.53K	19.03M	76.76K	21.24K	326K
Divestitures	-	1.26M	-	-	-
Investment in Marketable and Equity Securities, Total	-	-130M	-	-	-10M
Other Investing Activities, Total	-	3M	-	-	-7.28M
Cash from Investing	-108M	-202M	-299M	-262M	-216M
Short Term Debt Issued, Total	120M	100M	20M	70M	310M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	120M	100M	20M	70M	310M
Short Term Debt Repaid, Total	-130M	-80M	-120M	-	-180M
Long-Term Debt Repaid, Total	-	-8.7M	-6.17M	-7.67M	-8.93M
Total Debt Repaid	-130M	-88.7M	-126M	-7.67M	-189M
Issuance of Common Stock	-	580M	27.56M	25.3M	22.17M
Repurchase of Common Stock	-536K	-272K	-	-	-320K
Common Dividends Paid	-16.2M	-47.13M	-80.84M	-178M	-467M
Common & Preferred Stock Dividends Paid	-16.2M	-47.13M	-80.84M	-178M	-467M
Other Financing Activities, Total	11.66M	-5.95M	1.02M	6.69M	4.87M
Cash from Financing	-15.08M	538M	-158M	-84.17M	-319M
Foreign Exchange Rate Adjustments	-22.54K	-125K	-89.63K	200K	-109K
Net Change in Cash	-1.09M	643M	-171M	-28.34M	-118M
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	73.86M	103M	134M	110M	215M
Levered Free Cash Flow	-16.68M	127M	-133M	-20.83M	208M
Unlevered Free Cash Flow	-12.97M	131M	-133M	-19.94M	211M
Change In Net Working Capital	23.76M	10.91M	68.98M	37.19M	-36.81M
Net Debt Issued / Repaid	-10M	11.3M	-106M	62.33M	121M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	7.25	11.32	8.33	8.53	12.3
Return on Total Capital	9.16	13.47	9.56	9.74	14.27
Return On Equity %	14.73	20.52	14.62	14.81	20.59
Return on Common Equity	14.07	19.21	14.62	14.81	20.59
Margin Analysis
Gross Profit Margin %	72.72	77.72	78.39	76.81	78.16
SG&A Margin	46.66	44.41	47.64	47	45.06
EBITDA Margin %	21.82	28.88	23.64	23.02	25.72
EBITA Margin %	15.39	23.43	18.54	17.81	21.38
EBIT Margin %	15.31	23.38	18.5	17.71	21.02
Income From Continuing Operations Margin %	13.57	20.34	16.94	16.36	17.4
Net Income Margin %	12.77	18.94	16.94	16.36	17.4
Net Avail. For Common Margin %	12.77	18.94	16.94	16.36	17.4
Normalized Net Income Margin	8.2	13.02	11.96	11.3	13.06
Levered Free Cash Flow Margin	-2.42	12.38	-10.66	-1.42	10.7
Unlevered Free Cash Flow Margin	-1.88	12.75	-10.62	-1.36	10.88
Asset Turnover
Asset Turnover	0.76	0.78	0.72	0.77	0.94
Fixed Assets Turnover	1.37	1.91	2.01	1.91	2.12
Receivables Turnover (Average Receivables)	4.73	6.23	6.71	6.44	7.26
Inventory Turnover (Average Inventory)	2.54	2.85	2.52	2.64	2.93
Short Term Liquidity
Current Ratio	1.38	3.69	5.68	3.48	1.8
Quick Ratio	0.93	3.23	4.69	2.83	1.41
Operating Cash Flow to Current Liabilities	0.57	1.15	1.88	1.22	0.9
Days Sales Outstanding (Average Receivables)	77.31	58.59	54.39	56.67	50.42
Days Outstanding Inventory (Average Inventory)	144.33	128.02	145.01	138.5	124.85
Average Days Payable Outstanding	34.44	14.41	19.93	19.08	14.61
Cash Conversion Cycle (Average Days)	187.2	172.2	179.47	176.09	160.65
Long Term Solvency
Total Debt/Equity	11.53	8.28	0.89	4.68	13.51
Total Debt / Total Capital	10.34	7.64	0.88	4.47	11.91
LT Debt/Equity	-	0.53	0.43	0.13	0.56
Long-Term Debt / Total Capital	-	0.49	0.43	0.13	0.49
Total Liabilities / Total Assets	28.13	20.3	12.94	16.5	25.12
EBIT / Interest Expense	17.76	40.11	246.62	180.77	71.49
EBITDA / Interest Expense	25.31	51.23	324.07	240.77	88.98
(EBITDA - Capex) / Interest Expense	7.09	35.36	4.88	58.59	54.2
Total Debt / EBITDA	0.53	0.36	0.05	0.23	0.42
Net Debt / EBITDA	0.28	-1.87	-1.65	-1.16	-0.3
Total Debt / (EBITDA - Capex)	1.9	0.53	3.02	0.94	0.7
Net Debt / (EBITDA - Capex)	1.02	-2.71	-109.57	-4.76	-0.5
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	26.96	49.26	21.59	17.42	32.42
Gross Profit, 1 Yr. Growth %	26.7	59.52	22.64	15.05	34.74
EBITDA, 1 Yr. Growth %	92.51	88.34	-0.7	13.64	46.88
EBITA, 1 Yr. Growth %	176.27	112.54	-4.07	11.91	57.45
EBIT, 1 Yr. Growth %	181.2	114.37	-3.79	12.43	57.13
Earnings From Cont. Operations, 1 Yr. Growth %	216.7	123.74	1.23	13.39	40.84
Net Income, 1 Yr. Growth %	145.11	121.31	8.72	13.39	40.84
Normalized Net Income, 1 Yr. Growth %	111.07	128.1	11.73	20.23	53
Diluted EPS Before Extra, 1 Yr. Growth %	140	120.18	1.27	12.2	39.86
Accounts Receivable, 1 Yr. Growth %	21.35	7.83	14.27	29.31	10.25
Inventory, 1 Yr. Growth %	-14.47	35.17	32.43	11.25	12.92
Net Property, Plant and Equip., 1 Yr. Growth %	11.31	3.92	26.86	20.32	18.49
Total Assets, 1 Yr. Growth %	13.3	74.68	5.7	13.51	5.13
Tangible Book Value, 1 Yr. Growth %	20.87	100.75	15.36	5.7	-9.5
Common Equity, 1 Yr. Growth %	20	97.09	15.46	8.86	-5.73
Cash From Operations, 1 Yr. Growth %	64.9	151.28	-6.74	10.94	31.3
Capital Expenditures, 1 Yr. Growth %	54.56	-12.11	214.79	-12.45	-24.15
Levered Free Cash Flow, 1 Yr. Growth %	-270.35	-1.12K	-204.68	-80.03	-1.02K
Unlevered Free Cash Flow, 1 Yr. Growth %	-203.13	-1.59K	-201.24	-80.78	-1.08K
Dividend Per Share, 1 Yr. Growth %	99.78	160.04	130.73	245.37	-43.25
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	26.38	37.66	34.72	19.49	24.7
Gross Profit, 2 Yr. CAGR %	27.16	42.17	39.87	18.78	24.51
EBITDA, 2 Yr. CAGR %	79.35	95.02	36.92	6.54	29.68
EBITA, 2 Yr. CAGR %	201.46	150.59	43	4.01	33.38
EBIT, 2 Yr. CAGR %	211.46	153.17	43.61	4	32.91
Earnings From Cont. Operations, 2 Yr. CAGR %	222.1	166.19	50.5	7.14	26.37
Net Income, 2 Yr. CAGR %	153.8	132.9	55.12	11.03	26.37
Normalized Net Income, 2 Yr. CAGR %	143.94	123.6	59.64	11.36	35.63
Diluted EPS Before Extra, 2 Yr. CAGR %	151.96	129.85	49.4	6.55	25.33
Accounts Receivable, 2 Yr. CAGR %	21.77	14.39	11	21.56	19.4
Inventory, 2 Yr. CAGR %	10.14	7.52	33.79	21.38	12.08
Net Property, Plant and Equip., 2 Yr. CAGR %	11.45	7.55	14.82	23.55	19.4
Total Assets, 2 Yr. CAGR %	16.75	40.68	35.88	9.53	9.24
Tangible Book Value, 2 Yr. CAGR %	12.3	55.77	52.18	10.43	-2.19
Common Equity, 2 Yr. CAGR %	11.83	53.78	50.85	12.11	1.31
Cash From Operations, 2 Yr. CAGR %	66.61	103.56	53.08	1.71	20.69
Capital Expenditures, 2 Yr. CAGR %	54.54	16.55	66.34	66.01	-18.51
Levered Free Cash Flow, 2 Yr. CAGR %	-12.82	260.52	226.33	-59.54	41.16
Unlevered Free Cash Flow, 2 Yr. CAGR %	-26.28	222.76	288.21	-61	42.77
Dividend Per Share, 2 Yr. CAGR %	0	127.93	144.95	182.29	40
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	24.14	33.58	32.08	28.68	23.65
Gross Profit, 3 Yr. CAGR %	23.68	37.15	35.34	31.05	23.88
EBITDA, 3 Yr. CAGR %	22.52	85.22	55.85	28.93	18.87
EBITA, 3 Yr. CAGR %	32.87	174.38	82.13	32.12	19.81
EBIT, 3 Yr. CAGR %	33.37	180.68	83.38	32.36	19.34
Earnings From Cont. Operations, 3 Yr. CAGR %	34.47	185.26	92.86	36.95	17.37
Net Income, 3 Yr. CAGR %	30.66	142.47	80.67	39.73	20.19
Normalized Net Income, 3 Yr. CAGR %	27.99	141.57	77.44	41.42	23.8
Diluted EPS Before Extra, 3 Yr. CAGR %	30.13	140.87	74.96	35.76	16.7
Accounts Receivable, 3 Yr. CAGR %	16.29	16.93	14.35	16.8	17.66
Inventory, 3 Yr. CAGR %	7.6	17.92	15.25	25.81	18.49
Net Property, Plant and Equip., 3 Yr. CAGR %	7.01	8.88	13.64	16.62	21.84
Total Assets, 3 Yr. CAGR %	12.6	33.53	27.89	27.97	8.05
Tangible Book Value, 3 Yr. CAGR %	7.75	36.29	40.93	34.77	3.34
Common Equity, 3 Yr. CAGR %	7.42	35.08	39.77	35.31	5.82
Cash From Operations, 3 Yr. CAGR %	55.17	91.06	56.92	37.5	10.75
Capital Expenditures, 3 Yr. CAGR %	54.56	28.04	62.31	34.3	27.86
Levered Free Cash Flow, 3 Yr. CAGR %	79.8	79.66	138.73	18.52	17.75
Unlevered Free Cash Flow, 3 Yr. CAGR %	135.76	76.41	119.3	31.32	17.29
Dividend Per Share, 3 Yr. CAGR %	0	37.51	128.86	174.67	65.37
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	19.1	24.83	28.27	27.76	29.08
Gross Profit, 5 Yr. CAGR %	20.07	25.75	29.92	29.48	30.9
EBITDA, 5 Yr. CAGR %	16.06	25.37	29.32	48.54	44.97
EBITA, 5 Yr. CAGR %	25.15	32.69	38.69	86.25	61.04
EBIT, 5 Yr. CAGR %	25.59	32.98	39.07	88.69	61.23
Earnings From Cont. Operations, 5 Yr. CAGR %	33.57	30.96	40.66	92.81	62.86
Net Income, 5 Yr. CAGR %	31.97	29.11	39.94	77.41	56.6
Normalized Net Income, 5 Yr. CAGR %	33.17	31.96	40.88	77.22	56.82
Diluted EPS Before Extra, 5 Yr. CAGR %	23.9	21.44	37.52	73.85	53.08
Accounts Receivable, 5 Yr. CAGR %	13.8	11.92	14.15	18.76	16.34
Inventory, 5 Yr. CAGR %	12.04	13.93	17.4	19.29	13.97
Net Property, Plant and Equip., 5 Yr. CAGR %	2	4.36	10.07	14.52	15.91
Total Assets, 5 Yr. CAGR %	8.21	18.52	21.39	23.36	20.08
Tangible Book Value, 5 Yr. CAGR %	12.6	21.61	23.7	25.29	21.78
Common Equity, 5 Yr. CAGR %	11.84	20.88	23.04	25.37	22.89
Cash From Operations, 5 Yr. CAGR %	41.63	61.29	54.33	48.48	41.28
Capital Expenditures, 5 Yr. CAGR %	87.34	92.24	59.17	42.05	23.21
Levered Free Cash Flow, 5 Yr. CAGR %	-9.34	151.88	115.45	-1.04	84.23
Unlevered Free Cash Flow, 5 Yr. CAGR %	-17.88	108.34	166.34	-3.54	75.83
Dividend Per Share, 5 Yr. CAGR %	-	39.03	43.1	83.35	88.02